ALNYLAM PHARMACEUTICALS, INC.: capex
| Value | {"amount": 19617000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-03-31 |
| Status | current |
| Entity | ALNYLAM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:50.761763+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ea0e2889-4077-40c4-94cb-02974e91088d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001178670-20-000007Retrieved: 2026-08-19T11:51:50.761763+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178670/capex/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ea0e2889-4077-40c4-94cb-02974e91088d
History
- no predecessors — first report